Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Bone disease in prostate cancer
Adnan Nagrial, Lisa Horvath
Cancers
|
May 16, 2023
Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients
Alison Lewis, Adnan Nagrial
Advances in Experimental Medicine and Biology
|
June 27, 2020
Chimeric Antigen Receptors for the Tumour Microenvironment
Rosemary Habib, Adnan Nagrial, Kenneth Micklethwaite, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Brooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
International Journal of Molecular Sciences
|
May 13, 2023
Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies
Nicholas McNamee, Ines Pires da Silva, Adnan Nagrial, et al.
Internal Medicine Journal
|
December 22, 2025
Trainee experiences and attitudes to phase 1 oncology trials: a cross-sectional survey of Australian medical oncology trainees
Roger Liang, Raja Chaganti, Su Saint Lee, et al.
International Journal of Integrated Care
|
April 28, 2025
Developing an Integrated Service Planning Tool: Lessons Learnt from Planning the WSLHD Thoracic Oncology Program
Kylie Smythe, David Greenfield, Anita Calderan, et al.
Thoracic Cancer
|
January 10, 2023
Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study
Emma Boys, Bo Gao, Rina Hui, et al.
Cancer Reports (Hoboken, N.J.)
|
October 8, 2025
Long-Term Outcomes and Toxicities in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens
Meghana Maddula, Lauren J Brown, Venessa Chin, et al.
The Oncologist
|
April 5, 2021
Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates
Dmitrii Shek, Scott A Read, Adnan Nagrial, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Bone disease in prostate cancer
Adnan Nagrial, Lisa Horvath
Cancers
|
May 16, 2023
Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients
Alison Lewis, Adnan Nagrial
Advances in Experimental Medicine and Biology
|
June 27, 2020
Chimeric Antigen Receptors for the Tumour Microenvironment
Rosemary Habib, Adnan Nagrial, Kenneth Micklethwaite, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Brooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
International Journal of Molecular Sciences
|
May 13, 2023
Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies
Nicholas McNamee, Ines Pires da Silva, Adnan Nagrial, et al.
Internal Medicine Journal
|
December 22, 2025
Trainee experiences and attitudes to phase 1 oncology trials: a cross-sectional survey of Australian medical oncology trainees
Roger Liang, Raja Chaganti, Su Saint Lee, et al.
International Journal of Integrated Care
|
April 28, 2025
Developing an Integrated Service Planning Tool: Lessons Learnt from Planning the WSLHD Thoracic Oncology Program
Kylie Smythe, David Greenfield, Anita Calderan, et al.
Thoracic Cancer
|
January 10, 2023
Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study
Emma Boys, Bo Gao, Rina Hui, et al.
Cancer Reports (Hoboken, N.J.)
|
October 8, 2025
Long-Term Outcomes and Toxicities in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens
Meghana Maddula, Lauren J Brown, Venessa Chin, et al.
The Oncologist
|
April 5, 2021
Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates
Dmitrii Shek, Scott A Read, Adnan Nagrial, et al.
Page
of 8